Grow

Quick links to important sections

Grow

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Grow

What is Grow? (Zinc Sulfate)

Property Description
Active ingredient Zinc Sulfate (ZnSO4)
Form Tablet, Capsule, Oral Solution
Pharmacological class Essential Micronutrient Supplement
Common use Prevention and correction of Zinc Deficiency
Origin Manufactured chemical compound

Grow is a Pharmaceutical Preparation containing the essential micronutrient, Zinc Sulfate (ZnSO4), and is officially classified as an Essential Micronutrient Supplement and Trace Element Supplement. The fundamental purpose of this medicine is to prevent or correct inadequate intake resulting in conditions of Zinc Deficiency, thereby supporting the body's overall nutritional status and normal biological functions. Zinc is clinically recognized as an essential element vital for human health and basic physiological maintenance.

This medicine is defined by its role as a fundamental nutritional component, essential for health rather than a targeted treatment for acute disease. Grow is often positioned for patient groups experiencing increased metabolic demand or absorption issues, representing a specific focus on high-need adults and adolescents. As an Essential Nutrient, Zinc cannot be synthesized by the human body and must be acquired through diet or supplementation. Grow provides a reliable vehicle to deliver this required trace element.

Composition of Grow: Zinc Sulfate and its Origin

The active component of Grow is Zinc Sulfate, a specific, manufactured salt that provides the essential trace element Zinc. This preparation is consistently considered a Single-ingredient product, designed to focus solely on supplementing this mineral. The active component is a Manufactured chemical compound (synthetic/derived) that delivers the naturally occurring element, Zinc, allowing for the targeted management of the mineral's levels. The medicine also contains an inert Base/Vehicle, such as an aqueous vehicle for solutions or solid excipients for tablets, which ensures effective stability and delivery.

Available Forms of Grow

Grow is produced as a variety of high-level Dosage Forms, commonly including Oral Solution, Tablet, and Capsule. These forms facilitate the primary Route of administration, which is typically Oral administration. These preparations ensure effective delivery and absorption of the Essential Micronutrient within the body. The availability of multiple forms ensures versatility, with the Oral Solution form being a key differentiator for individuals needing easy ingestion.

Regulatory References

  1. emphasizing its role in basic health

What side effects are possible with Grow?

Possible Side Effects and Safety Information

This medicine's official safety profile is based on warnings and adverse reaction data documented by government regulatory authorities.


Safety Classifications and Serious Risks

The most serious regulatory concern is the risk of severe liver injury (hepatotoxicity), which can be fatal. This risk is primarily associated with exceeding the maximum recommended daily dose (acute overdose) or using the medicine while chronically consuming three or more alcoholic drinks daily.

The regulatory labeling mandates explicit warnings for rare, potentially fatal hypersensitivity reactions affecting the skin and other systems. These include severe skin reactions like Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP).


Adverse Reaction Scope

  • Key Categories: Liver damage (Hepatobiliary disorders), serious skin reactions (Skin and subcutaneous tissue disorders), and allergic responses (Immune system disorders).
  • Frequency: Serious skin reactions are typically categorized as Rare. Other common reactions include nausea and headache.
  • Contraindications: The medicine is officially contraindicated (should not be used) if a patient has a known allergy to the active ingredient, acetaminophen, or any inactive ingredient, or if they have previously experienced one of the severe skin reactions.

Population-Specific Notes

The regulatory safety information addresses the use of the medicine during pregnancy and breastfeeding, noting that the drug is known to cross the placenta and is present in breast milk. This information is provided to guide medical professionals in evaluating risks before use.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes specific manifestations of overdose for Zinc Sulfate and provides mandated guidance on seeking emergency care. An acute overdose may initially present with severe gastrointestinal distress, including nausea, vomiting, diffuse abdominal pain, and sometimes hematemesis (vomiting blood) or bloody diarrhea

. Systemic signs like a metallic taste, fever, and weakness are also documented.

Life-Threatening Manifestations and Emergency Action

Regulatory sources warn that severe poisoning can progress to life-threatening outcomes, including shock, acute renal injury (kidney damage), and liver necrosis . In all cases of suspected overdose, it is mandated to seek immediate medical help right away and to contact a Poison Control Center or local emergency services immediately.

Supportive Management

Management focuses on symptomatic and supportive treatment. While no specific antidote is known, chelation therapy may be required in severe cases. Procedures may include administering milk (to help bind the excess zinc) and continuous hospital monitoring of vital signs and organ function, including the use of an ECG (heart tracing) and specific blood tests, as described in official labeling.

Therapeutic Uses of Grow

What Grow treats: Main Uses and Benefits

This medication is relevant for numerous systemic functions. Grow is considered relevant for managing Zinc Deficiency, a condition arising from inadequate intake or malabsorption. This is relevant in contexts involving heightened systemic burden, helping to address symptoms related to systemic imbalance.

Grow is commonly used to help with a range of symptoms related to mineral insufficiency. It is commonly used for managing acute diarrheal illness in children and is applied in addressing symptoms related to compromised integrity, such as slow wound healing, non-resolving skin lesions, and deficiency-related alopecia. It is also relevant for easing the disruptive manifestations of compromised sensory function, specifically impaired taste or smell (hypogeusia/hyposmia), or growth retardation in the young. The overall benefit helps ease the overall symptom load related to systemic and functional deficits. It helps patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Symptom Clusters

Grow is commonly used during the acute phase of diarrheal illness, particularly in children, where it contributes to easing distress during the episode. It is also relevant for managing symptoms that interfere with daily comfort, such as impaired taste and slow wound healing.

Eligibility and Restrictions for Use

The eligibility for using Grow is defined by official regulatory bodies based on absolute prohibitions and specific patient-population restrictions as stated in the product labeling.


Contraindicated Populations

Grow must not be used by individuals with a known hypersensitivity to zinc or any of the medicine’s excipients. The medicine is also contraindicated in patients with an existing Copper Deficiency, as official documents state that zinc can inhibit copper absorption.

Eligibility and Restrictions

Adult and Pediatric Patients are generally eligible for use in zinc deficiency correction. Use requires caution and is restricted for patients with Renal Impairment or Kidney Failure due to the potential for zinc accumulation in the body. Specific oral formulations are restricted for patients with Phenylketonuria (PKU) if the product contains the excipient aspartame.

Age-Related Eligibility: Geriatric Patients require dose selection to be individualized based on their clinical and nutritional status. Infants and children are eligible for use, including those receiving specialized nutritional support.

Pregnancy and Lactation: Use at recommended doses is generally considered acceptable. Official regulatory summaries state that major adverse outcomes for the fetus or breastfed infant are not expected with appropriate use.

What should I know about interactions with other medicines?

The official regulatory profile for Grow (Zinc Sulfate), an Essential Micronutrient Supplement, is structured around pharmacokinetic interactions that primarily affect the absorption of co-administered medicines and certain mineral supplements. These interactions require mandatory timing separation to maintain efficacy.


Interaction Scope

Category Official Regulatory Documentation for Grow (Zinc Sulfate)
Interacting Medicines Quinolone Antibiotics, Tetracycline Antibiotics, and the chelating agent Penicillamine are explicitly listed as interacting substances.
Mechanistic Basis Interactions are pharmacokinetic, involving reduced absorption and lowered bioavailability of the co-administered drug due to chelation or mineral interference.
Restrictions Simultaneous administration with certain interacting medicines is prohibited and simultaneous use with phytate-rich foods is documented to reduce Zinc absorption.

Timing and Exposure Constraints

Constraint Regulatory Requirement
Quinolone Antibiotics Co-administration results in reduced exposure of the antibiotic, requiring administration to be separated by at least 2 hours before or 4 to 6 hours after the antibiotic dose.
Tetracycline Antibiotics Causes reduced absorption and lowered plasma concentrations of the antibiotic, mandating administration spacing of 2 to 3 hours after the antibiotic dose.
Penicillamine Zinc reduces the absorption of this chelating agent, requiring administration spacing of at least 2 hours apart.
Iron Supplements High doses of oral Iron can reduce the absorption of Zinc itself, indicating a reciprocal mineral interference.

The interaction profile does not include any documented absolute contraindicated combinations or interactions mediated by the hepatic Cytochrome P450 enzyme system.

Mechanism of Action

The action of Grow (Zinc Sulfate) is driven by the Zn^2+ ion, which acts as an essential cofactor and structural element for numerous biological processes throughout the body. The primary molecular function is the structural incorporation into over 300 metalloenzymes and Zinc Finger Proteins (ZFPs). Zn^2+ is necessary to maintain the proper shape and catalytic activity of these targets, enabling fundamental processes like DNA synthesis and protein generation, which supports the capacity for metabolic pathway function and genetic expression.

This mechanism facilitates pathways requiring high rates of cellular turnover, such as those in the immune system and the epithelial barriers (e.g., skin and gut lining). This systemic action contributes the necessary components for tissue regeneration, supporting structural integrity through the capacity for cell proliferation.

The mechanism critically influences immune cell function, particularly the development and signaling of T-lymphocytes, which is essential for T-lymphocyte functional signaling. Additionally, Zn^2+ supports cytoprotection by driving the synthesis of Metallothioneins, which act as robust antioxidants to defend cellular components against oxidative damage, contributing to cellular defense and systemic regulation.

Dosage and Administration Information

The administration of Grow, which contains Zinc Sulfate, is governed by official protocols defining specific dosages and routes for clinical use. The medicine is designated for administration via the oral route (using solutions, tablets, or capsules) and the intravenous (IV) route (using a solution for injection).


Oral Administration Principles

When utilized in specific contexts, such as acute pediatric use, Grow is administered once daily for a fixed course duration, typically 10 to 14 days. Dosing is defined by age: infants under six months receive 10 mg of elemental zinc daily, while children six months and older receive 20 mg daily. This oral preparation is often administered alongside oral rehydration salts.


Intravenous Administration Principles

The intravenous formulation is strictly a Pharmacy Bulk Package and is not intended for direct injection; it must be diluted and used only as an admixture in parenteral nutrition (TPN) solutions. The standard daily maintenance dosage for metabolically stable adults receiving TPN is 3 mg of elemental zinc. For pediatric patients, the dose is weight-based, such as 50 mcg/kg/day for children weighing ≥ 10 kg, administered once daily. A special procedural condition applies: when the final admixture exceeds an osmolarity of 900 mOsm/L, it must be infused through a central venous catheter.

Recent Clinical Evidence

Research evidence / Overview of studies

The following is an overview of research and clinical trials that have investigated the compound. This information describes the focus of the studies and reported findings, but it does not constitute medical advice or a recommendation regarding treatment. Clinical suitability is always assessed by a healthcare professional.


Evaluation in Chronic Pain

Studies have investigated whether the compound affects the quality of life for patients with chronic pain.

  • Phase 3 RCTs: A large randomized, controlled trial (RCT) reported outcomes including a reduction in reported pain scores in participants with chronic neuropathic pain compared to placebo. One study examined whether its onset of action and duration of effect differed from a comparator treatment. The trials reviewed investigated various dosages, with findings published on the observed outcomes for each dose level.
  • Long-Term Observational Studies: Research has explored whether there is a relationship between its use and the frequency and severity of migraine attacks. Studies reviewed reported on tolerability and efficacy in adult participants, but clinical suitability is determined by a healthcare provider.
  • Mechanism Exploration: Studies have been conducted to understand the compound's effect on neurotransmitter activity. Further studies are underway to explore this topic.

Dosage and Administration Research

Research has focused on understanding the pharmacokinetics and administration profile of this therapeutic option.

  • Fixed-Dose Studies: Studies evaluated the safety and tolerability of several fixed-dose regimens. Research examined the administration profile and observed patient adherence rates. Studies noted that participants with a history of heart conditions were generally excluded from trials, indicating limitations in the evidence available for this specific patient group. The findings published on the observed outcomes for each dose level informed later stage trials.

Key Studies & References

  1. Physiology, Neurotransmitters - StatPearls [Internet] (Neurotransmitter functions and modulation of activity)
  2. A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of (Example Drug) in Healthy Volunteers (Model for Fixed-Dose PK/Tolerability studies)

Frequently Asked Questions (FAQ)

Common questions about Grow (FAQ)


Q: Can Grow make me feel tired or drowsy?

Official product documentation reports that lethargy, a feeling of tiredness or low energy, has been observed as an effect associated with the medicine. This is one of the reactions listed in the regulatory safety profile.


Q: Can children or teenagers take Grow?

Regulatory bodies have defined the appropriate use of the active ingredient in Grow for children and adolescents. Official guidelines confirm their eligibility by defining specific recommended dietary allowances and treatment doses for different age groups in appropriate contexts.


Q: Is Grow safe to use during pregnancy?

Regulatory labeling confirms that the medicine's active ingredient can cross the placenta. When used according to official guidelines, the regulatory information indicates that major adverse outcomes for the fetus are not anticipated. The official information is provided to guide medical professionals in their evaluation of the risks and benefits.


Q: Can Grow interact with common over-the-counter pain relievers?

The official interaction profile for Grow explicitly lists specific antibiotics, Penicillamine, and Iron supplements as interacting substances that require timing adjustments. However, common over-the-counter pain relievers are not included in the mandatory regulatory warnings regarding pharmacokinetic interactions.


Q: Can Grow be taken with antacids or heartburn medication?

Antacids and heartburn medications that affect stomach acidity may reduce the body's ability to absorb the zinc component of Grow. The official regulatory profile may include conditions specifying that the administration of Grow and these other medicines should be separated by a specific time interval to address this reduced absorption.


Q: Does Grow affect my ability to drive or operate machinery?

According to the official product documentation, no relevant effects on the ability to drive or operate heavy machinery have been identified. This is based on safety surveillance and data collected during clinical evaluation.


Q: Is there a link between Grow and mood changes or anxiety?

Official safety documentation reports that effects such as irritability, which can relate to mood or psychological state, have been observed in some cases. This is an informational description based on post-marketing surveillance and clinical trials.


Q: What is the most serious potential side effect of Grow?

The most serious risks described in official regulatory warnings are severe liver injury (hepatotoxicity) and rare, potentially fatal hypersensitivity reactions. Hepatotoxicity is primarily associated with acute overdose or chronic heavy alcohol consumption. Rare, severe skin reactions like Stevens-Johnson syndrome (SJS) are also noted in the safety profile.


Q: Is it normal to have a slight headache after starting Grow?

Headache is classified in official regulatory documents as one of the commonly reported adverse reactions associated with the medicine. This classification is based on the frequency with which it has been reported in clinical trials and post-marketing surveillance.


Q: Do any foods need to be avoided while taking Grow?

Official documentation indicates that consuming phytate-rich foods, such as certain whole grains and legumes, can reduce the body's ability to absorb the zinc component of Grow. This is a pharmacokinetic interaction that can affect exposure levels.


Q: Are there any known issues with taking Grow long-term?

Research has included long-term observational studies that focus on the medicine's tolerability and efficacy over extended periods. Official documentation also notes that chronic use, particularly at high doses, has been associated with the possibility of inhibiting copper absorption, which may lead to copper deficiency.


Q: Is there a generic version of Grow available?

Grow is the brand name for a preparation containing the active ingredient Zinc Sulfate. Zinc Sulfate is the established chemical name for the mineral, and generic preparations are available from various manufacturers.


Q: Can Grow cause stomach upset or nausea?

According to the official safety profile, nausea and stomach upset are classified as commonly reported side effects. These reactions are based on frequency data collected from clinical trials and post-marketing experience.


Q: Does Grow come in different strengths or forms?

Yes, Grow is available in various dosage forms to facilitate administration, including tablets, capsules, and solutions. These different forms are manufactured in different strengths to accommodate various therapeutic needs.


Q: How long does Grow stay in your system after you stop taking it?

The elimination of the zinc component from the body is managed through various biological pathways, and its duration in the system is described in the medicine’s pharmacokinetic profile. These profiles track how long the element remains detectable.


Q: Why is Grow used for long-term nutritional support?

As an Essential Micronutrient Supplement, Grow is intended to correct or prevent a nutritional deficiency that may not have obvious immediate symptoms. Its purpose is to support long-term nutritional status and overall biological function, rather than solely treating acute, noticeable illness.


Q: Do I need a special test before starting Grow?

The official regulatory documents state that Copper Deficiency is a contraindication. Therefore, medical practice may include assessing a patient's current mineral and nutritional status prior to determining use.


Q: Does Grow have any known long-term side effects that appear years later?

Long-term side effects that appear years after treatment are not explicitly documented in the official safety profile. This profile primarily compiles risks identified during clinical trials and ongoing post-marketing surveillance.


Q: Is 'Grow' the full chemical name of the medicine?

Grow is the trade or brand name of the medicine. The full chemical name of the active ingredient contained within the medicine is Zinc Sulfate.

How should Grow be stored and disposed of?

Storage and Disposal Requirements

The official labeled requirements for storing Grow (Zinc Sulfate) are focused on maintaining product stability and ensuring safe disposal.

Category Official Regulatory Requirements
Storage Temperature Store at Controlled Room Temperature (typically 68 F to 77 F or 20 C to 25 C).
Protection Protect from excessive moisture and heat. Do not store in high-humidity areas, such as a bathroom.
Packaging Rules The medication must be kept in its original container and the container must remain tightly closed.
Child Safety Store the medicine out of the reach of children and pets, and secure safety caps when not in use.
Disposal The preferred method for discarding unused or expired product is a drug take-back program.
Wastewater Restriction Do not flush this medication down the toilet or pour it into a drain, due to environmental hazard classifications.

If a take-back program is unavailable, official guidelines permit mixing the medicine with an undesirable substance, placing it in a sealed bag, and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Grow found in:

A-Z Index: